MiR-155 at the heart of oncogenic pathways

Oncogene

Volumn 33, Issue 6, 2014, Pages 677-678

  Czyzyk Krzeska, M F ^a,b   Zhang, X ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; FEMALE; HUMANS; MICRORNAS; TRIPLE NEGATIVE BREAST NEOPLASMS; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 84893745579     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.26     Document Type: Review

References (12)

1. Kong W, He L, Richards EJ, Challa S, Xu C-X, Permuth-Wey J et al. Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer. Oncogene 2014; 33: 679-689.
2. Chen J, Wang B-C, Tang J-H. Clinical significance of MicroRNA-155 expression in human breast cancer. J Surg Oncol 2012; 106: 260-266.
3. Kong W, Yang H, He L, Zhao J-J, Coppola D, Dalton WS et al. MicroRNA-155 is regulated by the transforming growth factor B/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol 2008; 28: 6773-6784.
4. Jiang S, Zhang H-W, Lu M-H, He X-H, Gu H, Liu M-F et al. MicroRNA-155 functions as an oncomiR in breast cancer by targeting the Suppressor of Cytokine Signaling 1 gene. Cancer Res 2010; 70: 3119-3127.
5. Jiang S, Zhang LF, Zhang HW, Hu S, Lu MH, Liang S et al. A novel miR-155/miR-143 cascade controls glycolysis by regulating hexokinase 2 in breast cancer cells. EMBO J 2012; 31: 1985-1998.
6. Kong W, He L, Coppola M, Guo J, Esposito NN, Coppola D et al. MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer. J Biol Chem 2010; 285: 17869-17879.
7. Gironella M, Seux M, Xie MJ, Cano C, Tomasini R, Gommeaux J et al. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc Natl Acad Sci USA 2007; 104: 16170-16175.
8. Bruning U, Cerone L, Neufeld Z, Fitzpatrick SF, Cheong A, Scholz CC et al. MicroRNA-155 promotes resolution of hypoxia-inducible factor 1alpha activity during prolonged hypoxia. Mol Cell Biol 2011; 31: 4087-4096.
9. Babar IA, Czochor J, Steinmetz A, Weidhaas JB, Glazer PM, Slack FJ. Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells. Cancer Biol Ther 2011; 12: 908-914.
10. Chang S, Wang RH, Akagi K, Kim KA, Martin BK, Cavallone L et al. Tumor suppressor BRCA1 epigenetically controls oncogenic micro-RNA-155. Nat Med 2011; 17: 1275-1282.
11. Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA et al. Molecular portraits of human breast tumours. Nature 2000; 406: 747-752.
12. Koboldt DC, Fulton RS, McLellan MD, Schmidt H, Kalicki-Veizer J, McMichael JF et al. Comprehensive molecular portraits of human breast tumours. Nature 2012; 490: 61-70.